Portfolio company
Salve Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops a bioengineering platform for designing and testing viral gene therapies to treat genetic disorders for biotechnology and pharmaceutical organisations.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Spot Biosystems
This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.
Gene Therapy Delivery Methods
This company develops viral and non-viral vector platforms to provide genetic material delivery solutions for biotechnology firms and healthcare providers.
Forge Biologics
This company provides adeno-associated virus manufacturing services and develops gene therapies for biotechnology and pharmaceutical organisations.
Stridebio
This company develops engineered viral vectors and gene therapies for patients with rare genetic diseases.
Chameleon Biosciences
This company develops immune-evading gene therapy delivery platforms for pharmaceutical firms and patients with genetic disorders.
Nanograb
This company develops an artificial intelligence platform to design targeted gene delivery vectors and nanoparticles for pharmaceutical organisations developing genetic medicines.
Borea Therapeutics
The company develops bio-conjugated viral vectors for gene therapy to treat patients with genetic or chronic diseases.
Bitrobius Genetics
This company develops synthetic gene transfer technology for researchers and pharmaceutical firms to manufacture and deliver cell and gene therapies and vaccines.
